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Background: The present study is a meta-analysis of English articles comparing one-stage [laparo-
scopic common bile duct exploration or intra-operative endoscopic retrograde cholangiopancreatogra-
phy (ERCP)] vs. two-stage (laparoscopic cholecystectomy preceded or followed by ERCP) management
of common bile duct stones.
Methods: MEDLINE/PubMed and Science Citation Index databases (1990–2011) were searched for
randomized, controlled trials that met the inclusion criteria for data extraction. Outcomes were calculated
as odds ratios (ORs) with 95% confidence intervals (CIs) using RevMan 5.1.
Results: Nine trials with 933 patients were studied. No significant differences was observed between the
two groups with regard to bile duct clearance (OR, 0.89; 95% CI, 0.65–1.21), mortality (OR, 1.2; 95% CI,
0.32–4.52), total morbidity (OR, 0.75; 95% CI, 0.53–1.06), major morbidity (OR, 0.95; 95% CI, 0.60–1.52)
and the need for additional procedures (OR, 1.58; 95% CI, 0.76–3.30).
Conclusions: Outcomes after one-stage laparoscopic/endoscopic management of bile duct stones are
no different to the outcomes after two-stage management.
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Introduction
Common bile duct (CBD) stones are present in 3.4–7.2% of
patients presenting for a cholecystectomy.1–3
With the increasing availability and use of magnetic resonance
cholangio-pancreatography (MRCP) and endoscopic ultrasound
(EUS) for the accurate pre-operative prediction of choledoch-
olithiasis, there is no clear consensus regarding the optimal
management strategy of CBD stones. The authors previous meta-
analysis in 20064 comparing endoscopy and surgery vs. surgery
alone for the management of CBD stones concluded that similar
outcomes could be achieved with either approach. Since this time,
five randomized trials have been published.5–9 Therefore the aim
of the present study was to update the previous meta-analysis2 but
on this occasion compare one-stage management [laparoscopic
cholecystectomy (LC) plus laparoscopic common bile duct explo-
ration (LCBDE) OR intra-operative ERCP) with two-stage man-
agement [laparoscopic cholecystectomy preceded or followed by
endoscopic retrograde cholangiopancreatography (ERCP)].
Methods
This meta-analysis was conducted according to the recommenda-
tions of the PRISMA statement for reporting systematic reviews
and meta-analyses.10
Eligibility criteria for study selection
Publications were selected for review if they compared, in a
prospective, randomized, controlled way, two-stage laparoscopic/
Part of the present study was presented at the 19th International Congress of
the European Association for Endoscopic Surgery, Torino, Italy, 15 to 18 June
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endoscopic management [ERCP proceeded or followed by LC] vs.
one stage management (LCBDE or intra-operative ERCP) of
CBD stones in adults. Included are only documents published in
English (including one study with an in press status) between
1990 and 2011.
Information sources and search strategy
Relevant studies were identified by searching databases, lists of
articles and communication with experts. The electronic search
was applied to MEDLINE/PubMed and Science Citation Index
databases. Databases were searched from 1990 to 2011 for records
in English. The last search was run on 15 June 2011.
A hand-based search of reference lists of published articles and
review articles was performed to ensure inclusion of all possible
studies and exclude duplicates. Experts were also contacted to
acquire information for accepted articles or articles in press.
The following search items were used: common bile duct
stones/-calculi; bile duct stones/calculi; ERCP; endoscopic sphinc-
terotomy; and laparoscopic ductal clearance/choledochotomy/
bile duct exploration.
Study selection
Eligibility assessment for selecting studies for inclusion in the
meta-analysis was performed independently by the two authors.
Disagreements were resolved by consensus.
Data extraction and collection
Data were extracted using a standardized electronic form. The
primary outcomes used for meta-analysis were: successful duct
clearance, mortality, total morbidity (number of patients with at
least one complication), major morbidity (sepsis, cholangitis,
clinical pancreatitis, pneumonia, bleeding, acute myocardial inf-
arction, stroke, pulmonary embolus, early reoperation and con-
version to open surgery in the LCBDE group) and additional
procedures (any endoscopy or surgery for failed CBD clearance
or management of complications). Data were analysed on an
intention-to-treat basis.
Assessment of methodological quality and risk
of bias
Each included trial was assessed for quality using the CONSORT
checklist for reporting randomized trials.11 A point was given for
each criterion that was met (maximum score is 22).
Statistical analysis
A meta-analysis was performed using Review Manager Version 5.1
(The Nordic Cochrane Centre, Copenhagen, Denmark). For
dichotomous variables, odds ratios (OR) with 95% confidence
intervals (95% CI) were calculated. Fixed-effect and random-
effects models (owing to a number of small studies) were used. In
case of discrepancy between the two models, the random effects
results are reported; otherwise only the results of the fixed-effect
model are reported. The level of significance was set at P < 0.050.
Heterogeneity was evaluated using the I2-value. A funnel plot was
constructed to determine if there was any publication bias.
Results
The search strategy identified nine randomized trials5–9,12–15
(Fig. 1). Four studies compared ERCP followed by LC against
laparoscopic CBD surgery,5,7,8,12 two studies compared LC
followed by ERCP against laparoscopic CBD surgery13,14 and two
studies compared ERCP+LC against LC plus intra-operative
ERCP.6,9
The median (range) CONSORT score was 20 (17–21).
Outcomes for 933 patients (462 (49.5%) in the one-stage man-
agement and 471 (50.5%) in the two-stage management group)
were examined (Table 1). Forrest plots (Figs 2–6) were con-
structed comparing successful duct clearance, mortality, total
morbidity, major morbidity and the need for additional proce-
dures for the two-stage vs. the one-stage management group. Het-
erogeneity between studies was not significant or moderately
significant as shown in the individual figures.
Successful duct clearance was achieved in 342/471 (72.6%)
of patients in the two-stage group and in 344/462 (74.4%) in
the one-stage management group. No significant difference
between the two groups was observed [OR (fixed) = 0.89 (95%
CI = 0.65–1.21), P = 0.46].
Mortality was 4/471 (0.8%) in the two-stage management
group and 3/462 (0.6%) in the one-stage management group. No
658 records
identified through
the Database search
1 record identified
through other
sources
 643 records after duplicates
removed  
643 records
screened  
9 full text articles
assessed for
eligibility 
9 studies included in
meta-analysis  
634 records
excluded;
did not meet the
criteria 
Figure 1 Flow chart of the selection of studies eligible for data
extraction and analysis
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Table 1 Summary of randomized trials comparing two-stage (endoscopic common duct clearance and laparoscopic cholecystectomy) vs.
one-stage (laparoscopic surgery alone or combined with intra-operative endoscopy)
Study Author Year Treatment n Duct
clearance
successful
Mortality Morbidity
(Total)
Morbidity
(Major)
Additional
procedures
required
Length of
stay (median,
days)
1 Rhodes 1998 LC+ERCP 40 37 0 6 4 10 3.5
LC+LCBDE 40 30 0 7 2 10 1
2 Cuschieri 1999 ERCP+LC 133 82 2 17 9 17 9
LC+LCBDE 133 92 1 21 9 17 6
3 Sgourakis 2002 ERCP+LC 42 27 1 6 3 5 9
LC+LCBDE 36 24 1 5 2 4 7.4
4 Nathanson 2005 LC+ERCP 45 43 0 11 6 3 7.7
LC+LCBDE 41 40 0 12 7 3 6.4
5 Morino 2006 ERCP+LC 45 36 0 4 2 15 8
LC+ intra-operative
ERCP
46 44 0 5 4 2 4.3
6 Noble 2009 ERCP+LC 47 29 1 16 8 18 3 (PO stay)
LC+LCBDE 44 38 0 23 8 0 5 (PO stay)
7 Rogers 2010 ERCP+LC 55 30 0 5 0 1 5
LC+LCBDE 57 15 0 6 0 2 4
8 Bansal 2010 ERCP+LC 15 13 0 5 2 2 4
LC+LCBDE 15 14 0 6 2 1 4.2
9 Tzovaras 2011 ERCP+LC 49 45 0 6 5 5 5.5
LC+ intra-operative
ERCP
50 47 1 7 6 3 4
Totals
Two stage (endoscopy
followed by Surgery)
471 342 (72.6%) 4 (0.8%) 76 (16.1%) 39 (8.3%) 76 (16.1%)
One stage (LCBDE or
intra-operative
endoscopy)
462 344 (74.4%) 3 (0.6%) 92 (19.9%) 40 (8.6%) 42 (9%)
LC, laparoscopic cholecystectomy; ERCP, endoscopic retrograde cholangiopancreatography; LCBDE; laparoscopic common bile duct exploration;
PO, post-operative stay.
Study or subgroup
Rhodes 1998
Cuschieri 1999
Sgourakis 2002
Nathanson 2005
Morino 2006
Noble 2009
Bansal 2010
Rogers 2010
Tzovaras 2011
Total (95% CI)
Total events
Heterogeneity: chi² = 26.07, d.f. = 8 (P = 0.001); I² = 69%
Test for overall effect: Z = 0.74 (P = 0.46)
Events
37
82
27
43
36
29
13
30
45
342
Total
40
133
42
45
45
47
15
55
49
471
Events
30
92
24
40
44
38
14
15
47
344
Total
40
133
36
41
46
44
15
57
50
462
Weight
2.7%
41.6%
10.9%
2.2%
10.3%
17.7%
2.2%
7.9%
4.5%
100.0%
M-H, Fixed, 95% CI
4.11 [1.04, 16.29]
0.72 [0.43, 1.19]
0.90 [0.35, 2.30]
0.54 [0.05, 6.16]
0.18 [0.04, 0.90]
0.25 [0.09, 0.72]
0.46 [0.04, 5.75]
3.36 [1.52, 7.43]
0.72 [0.15, 3.39]
0.89 [0.65, 1.21]
Year
1998
1999
2002
2005
2006
2009
2010
2010
2011
Odds RatioOdds RatioOne stageTwo stage
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Two-stage managment One-stage management
Figure 2 Meta-analysis of successful bile duct clearance (fixed-effects model). Error bars indicate a 95% confidence interval (CI). A summary
of effects is shown as a diamond that spans the 95% CI
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significant difference between the two groups was observed [OR
(fixed) = 1.2 (95% CI = 0.32–4.52), P = 0.79].
Total patient morbidity was 76/471 (16.1%) in the two-
stage group and 92/462 (19.9%) in the one-stage group. No sig-
nificant difference between the two groups was observed [OR
(fixed) = 0.75 (95%CI = 0.53–1.06), P = 0.10].
Major patient morbidity was 39/471 (8.3%) in the two-
stage group and 40/462 (8.6%) in the one-stage group. No sig-
nificant difference between the two groups was observed [OR
(fixed) = 0.95 (95%CI = 0.60–1.52), P = 0.84].
Additional procedures were required in 76/471 (16.1%) in the
two-stage group and in 42/462 (9%) in the one-stage management
group. No significant difference between the two groups
was observed [OR (random) = 1.58 (95% CI = 0.76–3.30),
P = 0.22].
Discussion
This meta-analysis shows that both clinical practices (one- vs.
two- stage laparoscopic/endoscopic management of CBD stones)
have similar clinical outcomes. However, critical review of the
studies raised a number of issues.
As previously noted,4 the majority of trials are underpowered.
All but two studies8,12 have 50 patients or less in each arm. To
Study or subgroup
Rhodes 1998
Cuschieri 1999
Sgourakis 2002
Nathanson 2005
Morino 2006
Noble 2009
Rogers 2010
Bansal 2010
Tzovaras 2011
Total (95% CI)
Total events
Heterogeneity: chi² = 1.12, d.f. = 3 (P = 0.77); I² = 0%
Test for overall effect: Z = 0.27 (P = 0.79)
Events
0
2
1
0
0
1
0
0
0
4
Total
40
133
42
45
45
47
55
15
49
471
Events
0
1
1
0
0
0
0
0
1
3
Total
40
133
36
41
46
44
57
15
50
462
Weight
24.6%
26.2%
12.5%
36.7%
100.0%
M-H, Fixed, 95% CI
Not estimable
2.02 [0.18, 22.50]
0.85 [0.05, 14.15]
Not estimable
Not estimable
2.87 [0.11, 72.35]
Not estimable
Not estimable
0.33 [0.01, 8.38]
1.20 [0.32, 4.52]
Year
1998
1999
2002
2005
2006
2009
2010
2010
2011
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Two-stage management One-stage management
Odds RatioOdds RatioOne stageTwo stage
Figure 3 Mortality (fixed-effects model). Error bars indicate a 95% confidence interval (CI). A summary of effects is shown as a diamond that
spans the 95% CI
Study or subgroup
Rhodes 1998
Cuschieri 1999
Sgourakis 2002
Nathanson 2005
Morino 2006
Noble 2009
Rogers 2010
Bansal 2010
Tzovaras 2011
Total (95% CI)
Total events
Heterogeneity: chi² = 1.55, d.f. = 8 (P = 0.99); I² = 0%
Test for overall effect: Z = 1.65 (P = 0.10)
Events
6
17
6
11
4
16
5
5
6
76
Total
40
133
42
45
45
47
55
15
49
471
Events
7
21
5
12
5
23
6
6
7
92
Total
40
133
36
41
46
44
57
15
50
462
Weight
8.0%
24.8%
6.2%
12.8%
6.1%
21.2%
7.2%
5.4%
8.2%
100.0%
M-H, Fixed, 95% CI
0.83 [0.25, 2.74]
0.78 [0.39, 1.56]
1.03 [0.29, 3.72]
0.78 [0.30, 2.03]
0.80 [0.20, 3.19]
0.47 [0.20, 1.10]
0.85 [0.24, 2.96]
0.75 [0.17, 3.33]
0.86 [0.27, 2.76]
0.75 [0.53, 1.06]
Year
1998
1999
2002
2005
2006
2009
2010
2010
2011
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Two-stage management One-stage management
Odds RatioOdds RatioOne stageTwo stage
Figure 4 Morbidity (total) (fixed-effects model). Error bars indicate a 95% confidence interval (CI). A summary of effects is shown as a
diamond that spans the 95% CI
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detect a 20% (a = 0.05, power = 80%) difference in the rate of bile
duct clearance, 100 patients per arm would be required.
Severe complications after ERCP in specialized centres are
reported as low as 0.8%16 and was 2.6% in a multi-centre French
study.17 The severe complication rate of the two-stage group in the
present analysis was 8%. In addition, the ERCP success rate was
87% in the French study17 vs. 73% in the two-stage group of this
meta-analysis. This underscores the importance of having an
expert ERCP service when dealing with these patients.18
Laparoscopic common bile duct exploration has not found
widespread favour amongst the surgical community. It has
remained a procedure limited to experienced and/or enthusiastic
laparoscopic surgeons. Findings from these randomized trials may
not apply to the surgical community at large. A recent survey of
>16 000 cholecystectomies in Germany showed that two-stage
management was the preferred method in 99% of patients with
suspected CBD stones and there was a conversion rate of 43%
in patients with an attempted LCBDE.19 In contrast, a survey in
the UK among upper gastrointestinal surgeons showed that
61% perform laparoscopic CBD exploration, 25% advise post-
operative ERCP and 13% perform either LCBDE or ERCP when
they encounter CBD stones.20
Two of the included studies reported cost analysis.6,8 Both
found that the two-stage approach had significantly higher costs
(1319 USD difference in the USA study and 1005 Euro in the
Italian study). A non-randomized trial from Belgium reported
Study or subgroup
Rhodes 1998
Cuschieri 1999
Sgourakis 2002
Nathanson 2005
Morino 2006
Noble 2009
Bansal 2010
Rogers 2010
Tzovaras 2011
Total (95% CI)
Total events
Heterogeneity: chi² = 1.94, d.f. = 7 (P = 0.96); I² = 0%
Test for overall effect: Z = 0.21 (P = 0.84)
Events
4
9
3
6
2
8
2
0
5
39
Total
40
133
42
45
45
47
15
55
49
471
Events
2
9
2
7
4
8
2
0
6
40
Total
40
133
46
41
46
44
15
57
50
472
Weight
5.0%
23.3%
4.9%
17.6%
10.5%
19.0%
4.8%
14.8%
100.0%
M-H, Fixed, 95% CI
2.11 [0.36, 12.24]
1.00 [0.38, 2.60]
1.69 [0.27, 10.66]
0.75 [0.23, 2.44]
0.49 [0.08, 2.81]
0.92 [0.31, 2.72]
1.00 [0.12, 8.21]
Not estimable
0.83 [0.24, 2.93]
0.95 [0.60, 1.52]
Year
1998
1999
2002
2005
2006
2009
2010
2010
2011
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Two-stage management One-stage management
Odds RatioOdds RatioOne stageTwo stage
Figure 5 Morbidity (major) (fixed-effects model). Error bars indicate a 95% confidence interval (CI). A summary of effects is shown as a
diamond that spans the 95% CI
Study or subgroup
Rhodes 1998
Cuschieri 1999
Sgourakis 2002
Nathanson 2005
Morino 2006
Noble 2009
Rogers 2010
Bansal 2010
Tzovaras 2011
Total (95% CI)
Total events
Heterogeneity: tau² = 0.63; chi² = 18.14, d.f. = 8 (P = 0.02); I² = 56%
Test for overall effect: Z = 1.21 (P = 0.22)
Events
10
17
5
3
15
18
1
2
5
76
Total
40
133
42
45
45
47
55
15
49
471
Events
10
17
4
3
2
0
2
1
6
45
Total
40
133
36
41
46
44
57
15
50
462
Weight
15.8%
18.5%
12.4%
10.5%
11.3%
5.2%
6.5%
6.2%
13.6%
100.0%
M-H, Random, 95% CI
1.00 [0.36, 2.75]
1.00 [0.49, 2.05]
1.08 [0.27, 4.37]
0.90 [0.17, 4.76]
11.00 [2.34, 51.65]
55.81 [3.24, 962.29]
0.51 [0.04, 5.78]
2.15 [0.17, 26.67]
0.83 [0.24, 2.93]
1.58 [0.76, 3.30]
Year
1998
1999
2002
2005
2006
2009
2010
2010
2011
M-H, Random, 95% CI
0.01 0.1 1 10 100
Two-stage management One-stage management
Odds RatioOdds RatioSES
Figure 6 Additional procedures required (Random-effects model). Error bars indicate a 95% confidence interval (CI). A summary of effects
is shown as a diamond that spans the 95% CI
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that total hospital costs were significantly less after one-stage man-
agement (2636 vs. 4608 Euro in the two-stage arm).21 A US analy-
sis of five treatment strategies found that the most cost-effective
treatment of CBD stones was LC + intra-operative cholangiogra-
phy + postoperative ERCP.22 However, cost comparisons are very
difficult to make, not only between countries but also between
hospitals within a specific country.
The patient population in this meta-analysis is variable. There
were differences in the CBD stone diagnosis; some studies used
MRC before any intervention,5,6 whereas others used ERC or
intra-operative cholangiography.8,12,13 Some studies included
patients with acute cholangitis12,13 and others excluded these
patients.6,8 It should be noted that patients with cholecysto/
choledocholithiasis who undergone CBD stone clearance must
undergo a cholecystectomy (unless medically unfit) because of the
high risk of recurrent biliary events.23
In conclusion, this meta-analysis shows that the clinical
outcome after one-stage laparoscopic/endoscopic management of
bile duct stones is no different to the outcome after two-stage
management. Strategies can be based on a combination of local
expertise and availability of therapeutic resources.
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